Cleveland Clinic physician leader Brian Bolwell, MD, knows the importance of embracing constructive criticism.
From steroids to stem cells to direct-current brain stimulation, the latest in spinal cord injury management is the focus of the new episode of our Neuro Pathways podcast.
Suicidal ideation is reported in as many as 40% of patients with neurologic disorders. Our latest Neuro Pathways podcast explores mood disorder management in the setting of neurologic disease.
Most therapies in development for Alzheimer’s are focused on changing disease biology, with targets ranging from amyloid pathology to inflammation. A leader of our clinical trials program shares an update on drug development and diagnostics.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Emerging research is clarifying the role of untreated obstructive sleep apnea in comorbidities from arrhythmias to dementia. A leading clinical researcher explains the linkages and how treatment helps on multiple fronts.
The director of our Mobile Stroke Treatment Unit reflects on lessons from our first six years of experience, along with what’s on the horizon in mobile stroke care.
A movement disorder neurologist and a clinical health psychologist bring clarity to a complex condition that requires multidisciplinary management and sensitivity to unique patient needs.
A leading neuroradiologist shares insights from six years of using this advanced imaging technology for research and clinical purposes in conditions from multiple sclerosis to brain tumor.
A leader of our efforts in teleneurological care reviews where the field started, where it’s going and tips for others looking to expand their virtual neurological care offerings.
A psychiatrist who worked with the group that discovered ketamine’s antidepressant effects traces the path to the randomized trial he’s now leading to compare ketamine with electronconvulsive therapy.